Rationale for Use of an FDA-Cleared Delivery System for Administration of Inhaled Nitric Oxide in Patients Undergoing Magnetic Resonance Imaging

Rationale for Use of an FDA-Cleared Delivery System for Administration of Inhaled Nitric Oxide in Patients Undergoing Magnetic Resonance Imaging

Mauro Salas,1 Jim L Potenziano,2 Jaron Acker3 1Clinical Specialist, Children’s National Health System, Washington, DC, USA; 2Scientific Affairs, Mallinckrodt Pharmaceuticals, Bedminster, NJ, USA; 3Medical Device Marketing, Mallinckrodt Pharmaceuticals, Bedminster, NJ, USACorrespondence: Ma...

Full description

Bibliographic Details
Main Authors: Salas M, Potenziano JL, Acker J
Format: Article
Language:English
Published: Dove Medical Press 2021-01-01
Series:Medical Devices : Evidence and Research
Subjects:
critical care
drug delivery systems
magnetic resonance imaging
newborn
nitric oxide
Online Access:https://www.dovepress.com/rationale-for-use-of-an-fda-cleared-delivery-system-for-administration-peer-reviewed-article-MDER

Internet

https://www.dovepress.com/rationale-for-use-of-an-fda-cleared-delivery-system-for-administration-peer-reviewed-article-MDER

Similar Items